Targeting oxidative phosphorylation with lixumistat overcomes PARP inhibitor resistance in ovarian cancer

Sa Deok Hong, Nar Bahadur Katuwal, Mithun Ghosh, Seong Min Park, Ju Hyun Kim, Seul-Gi Kim, Min Sil Kang, Yong Wha Moon

Open source

DOI
10.1038/s41419-026-09140-y
Published
2026-08-07
Container
Cell Death & Disease
Publisher
Springer Science and Business Media LLC
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1038/s41419-026-09140-y,
  title = {Targeting oxidative phosphorylation with lixumistat overcomes PARP inhibitor resistance in ovarian cancer},
  author = {Sa Deok Hong and Nar Bahadur Katuwal and Mithun Ghosh and Seong Min Park and Ju Hyun Kim and Seul-Gi Kim and Min Sil Kang and Yong Wha Moon},
  year = {2026},
  journal = {Cell Death \& Disease},
  doi = {10.1038/s41419-026-09140-y},
  url = {https://doi.org/10.1038/s41419-026-09140-y}
}

RIS

TY  - JOUR
TI  - Targeting oxidative phosphorylation with lixumistat overcomes PARP inhibitor resistance in ovarian cancer
AU  - Sa Deok Hong
AU  - Nar Bahadur Katuwal
AU  - Mithun Ghosh
AU  - Seong Min Park
AU  - Ju Hyun Kim
AU  - Seul-Gi Kim
AU  - Min Sil Kang
AU  - Yong Wha Moon
PY  - 2026
JO  - Cell Death & Disease
DO  - 10.1038/s41419-026-09140-y
UR  - https://doi.org/10.1038/s41419-026-09140-y
ER  - 

APA

Hong, S. D., Katuwal, N. B., Ghosh, M., Park, S. M., Kim, J. H., Kim, S., Kang, M. S., & Moon, Y. W. (2026). Targeting oxidative phosphorylation with lixumistat overcomes PARP inhibitor resistance in ovarian cancer. Cell Death & Disease. https://doi.org/10.1038/s41419-026-09140-y

Source records